Table 2.
Pre-MDD and MDD consensus diagnoses.
| Diagnosis | Pre-MDD, n (%) | MDD, n (%) |
|---|---|---|
| ILD-NOS | 52 (41%) | 0 (0%) |
| HP | 20 (16%) | 21 (16.6%)∗ |
| IPF | 24 (19%) | 34 (27.0%)∗ |
| SR-ILD | 5 (4.0%) | 10 (8.0%) |
| NSIP | 6 (4.7%) | 6 (4.7%)∗ |
| OP | 3 (2.4%) | 2 (1.6%) |
| Drug toxicity | 4 (3.2%) | 4 (3.2%) |
| Asbestosis | 1 (0.8%) | 1 (0.8%) |
| Sarcoidosis | 4 (3.2%) | 1 (0.8%) |
| LIP | 1 (0.8%) | 1 (0.8%) |
| GL-ILD | 1 (0.8%) | 1 (0.8%) |
| Pulmonary ossification | 1 (0.8%) | 1 (0.8%) |
| Aspiration | 1 (0.8%) | 1 (0.8%) |
| HP/IPF | 2 (1.6%) | 0 (0%) |
| DIPNECH | 0 (0%) | 1 (0.8%) |
| ILA | 0 (0%) | 4 (3.2%) |
| Cystic disease | 1 (0.8%) | 0 (0%) |
| IPAF | 0 (0%) | 5 (4.0%) |
| Unclassifiable ILD | 0 (0%) | 27 (21.4%) |
| No ILD | 0 (0%) | 6 (4.7%) |
∗Includes provisional diagnoses (HP = 8, IPF = 4, and NSIP = 3). ILD = interstitial lung disease; ILD-NOS = interstitial lung disease-not otherwise specified; HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; SR-ILD = smoking-related ILD; NSIP = nonspecific interstitial pneumonia; OP = organising pneumonia; LIP = lymphocytic interstitial pneumonia; GL-ILD = granulomatous–lymphocytic interstitial lung disease; DIPNECH = diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; ILA = interstitial lung abnormality; IPAF = interstitial pneumonia with autoimmune features.